Vanguard Asset Management
FLGT icon

Vanguard Asset Management’s Fulgent Genetics FLGT Stock Holding History

Vanguard Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3K Sell
504
-11,292
-96% -$191K ﹤0.01% 2441
2026
Q1 		$188K Buy
+11,796
New +$256K ﹤0.01% 2372

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Asset Management's FLGT Position: Q2 2026 in Review

Vanguard Asset Management reduced its Fulgent Genetics (FLGT) stake by 96% in Q2 2026, selling an estimated $191K and leaving 504 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2441.

Vanguard Asset Management first reported a position in FLGT in Q1 2026 and has held it in 2 quarters since. The position peaked at $188K in Q1 2026. 125 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Vanguard Asset Management held 504 shares of Fulgent Genetics worth $10.3K as of Q2 2026.
  • Vanguard Asset Management sold 11,292 Fulgent Genetics shares in Q2 2026, an estimated $191K.
  • Fulgent Genetics made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #2441 holding.
  • Vanguard Asset Management first reported a position in Fulgent Genetics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Asset Management's Fulgent Genetics position peaked at $188K in Q1 2026.
  • 125 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.